The Western Star:
Brain scans may predict anxiety treatment response
JournalNews:
Economic adversity in childhood has lasting mental health impact
Reuters:
Earthquake aftermath reveals PTSD vulnerability runs in families

By Michael Smith, North American Correspondent, MedPage Today
NEW YORK, April 3 Much like investing on Wall Street, buying personalized genetic information can represent ownership of an expensive piece of paper with little or no value, researchers here warned.
At least four companies make claims that understanding the variability of cytochrome P450 (CYP450) enzymes will aid treatment with selective serotonin reuptake inhibitors (SSRIs), according to researchers led by Kathy Hudson, Ph.D., of the Johns Hopkins University Genetics and Public Policy Center here.
links: digg this del.icio.us technorati reddit
